Featured
-
-
Article
| Open AccessA digital image colorimetry system based on smart devices for immediate and simultaneous determination of enzyme-linked immunosorbent assays
- Shaghayegh Mirhosseini
- , Aryanaz Faghih Nasiri
- & Mohammadreza Kolahdouz
-
Article
| Open AccessProton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
- Keitaro Iida
- , Taku Naiki
- & Takahiro Yasui
-
Article
| Open AccessMulti-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy
- Zhixiong Su
- , Lijie You
- & Zhenhua Liu
-
Article
| Open AccessIdentification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer
- Yanjun Wang
- , Yi Tang
- & Kai Yao
-
Article
| Open AccessInvestigating the prognostic value of mTORC1 signaling in bladder cancer via bioinformatics evaluation
- Xin Yu
- , Wenge Li
- & Juanjuan Li
-
Article
| Open AccessIdentification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer
- Xiaoxu Chen
- , Zheng Qin
- & Haitao Wang
-
Article
| Open AccessEnhancing the image quality of blue light cystoscopy through green-hue correction and fogginess removal
- Shuang Chang
- , Micha E. Bermoy
- & Audrey K. Bowden
-
Article
| Open AccessScreening for a practical method to monitor the status of patients with metastatic bladder cancer at the circulating cell-gene level
- Ryota Ogura
- , Saya Ito
- & Osamu Ukimura
-
Article
| Open AccessTreatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
- Yuta Inoue
- , Takeshi Yamada
- & Osamu Ukimura
-
Article
| Open AccessDuality of the SVIL expression in bladder cancer and its correlation with immune infiltration
- Zhenyu Nie
- , Na Guo
- & Shufang Zhang
-
Article
| Open AccessHomologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients
- Nada Albarakati
- , Hanin Al-Ghamdi
- & Alaa Alshareeda
-
Article
| Open AccessUntargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry
- Joanna Nizioł
- , Krzysztof Ossoliński
- & Tomasz Ruman
-
Article
| Open AccessSurveillance of prognostic risk factors in patients with SCCB using artificial intelligence: a retrospective study
- Chenghao Zhanghuang
- , Zhaoxia Zhang
- & Bing Yan
-
Article
| Open AccessThe prognostic value of hedgehog signaling in bladder cancer by integrated bioinformatics
- Xin Yu
- , Wenge Li
- & Yue Xia
-
Article
| Open AccessCD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity
- Manh-Hung Do
- , Hien Duong Thanh
- & Chaeyong Jung
-
Article
| Open AccessNoninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up
- Jongsoo Lee
- , Ji Eun Heo
- & Young Deuk Choi
-
Article
| Open AccessValidation of the Japanese version of the Body Image Scale for bladder cancer patients
- Miho Sato
- , Takahiro Osawa
- & Nobuo Shinohara
-
Article
| Open AccessIdentification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer
- Gaomin Huang
- , Yawei Huang
- & Xiaoqing Xi
-
Article
| Open AccessA transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma
- Joshua I. Warrick
- , Margaret A. Knowles
- & David J. DeGraff
-
Article
| Open AccessPAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
- Hideki Furuya
- , Yuka Sasaki
- & Charles J. Rosser
-
Article
| Open AccessComprehensive analysis of autophagy related long non-coding RNAs in prognosis, immunity, and treatment of muscular invasive bladder cancer
- Wei Tan
- , Ye Yuan
- & Zili Hu
-
Article
| Open AccessA scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
- J. W. Van Hattum
- , E. M. Scutigliani
- & P. M. Krawczyk
-
Article
| Open AccessIn vitro assessment of intra-operative and post-operative environment in reducing bladder cancer recurrence
- Ryan Tsz-Hei Tse
- , Hongda Zhao
- & Jeremy Yuen-Chun Teoh
-
Article
| Open AccessMumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment
- T. Kloskowski
- , K. Szeliski
- & M. Pokrywczyńska
-
Article
| Open AccessPrognostic value of prostate volume in non-muscle invasive bladder cancer
- Won Sik Ham
- , Jee Soo Park
- & Jongchan Kim
-
Article
| Open AccessA tissue-engineered urinary conduit in a porcine urinary diversion model
- Arkadiusz Jundziłł
- , Piotr Kwieciński
- & Tomasz Drewa
-
Article
| Open AccessDetection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
- Georgi Tosev
- , Wasilijiang Wahafu
- & Stefan Duensing
-
Article
| Open AccessPrognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
- Matias Blomqvist
- , Ilmari Koskinen
- & Pekka Taimen
-
Article
| Open AccessEffect of intraoperative fluid volume on postoperative ileus after robot-assisted radical cystectomy
- Ji Sung Shim
- , Tae Il Noh
- & Seok Ho Kang
-
Article
| Open AccessMulti-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
- Guilhem Richard
- , Anne S. De Groot
- & Randy F. Sweis
-
Article
| Open AccessProteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
- Alberto Valdés
- , Athanasios Bitzios
- & Sara Bergström Lind
-
Article
| Open AccessDifferential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication
- Raquel Carrasco
- , Laura Izquierdo
- & Antonio Alcaraz
-
Article
| Open AccessA showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
- Friedemann Krentel
- , Franziska Singer
- & Roland Seiler
-
Article
| Open AccessSerial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model
- Valentin Baloche
- , Julie Rivière
- & Pierre Busson
-
Article
| Open AccessA bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture
- Elise Y. Cai
- , Jose Garcia
- & Hung-Ming Lam
-
Article
| Open AccessUBC9 coordinates inflammation affecting development of bladder cancer
- Xiaoliang Huang
- , Yuting Tao
- & Tianyu Li
-
Article
| Open AccessRecurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
- Nour-Al-Dain Marzouka
- , David Lindgren
- & Mattias Höglund
-
Article
| Open AccessAnalysis of open chromatin regions in bladder cancer links β-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer
- Aleyna Eray
- , Perihan Yağmur Güneri
- & Serap Erkek-Ozhan
-
Article
| Open AccessNon-muscle invasive bladder cancer tissues have increased base excision repair capacity
- Berna Somuncu
- , Selcuk Keskin
- & Meltem Muftuoglu
-
Article
| Open AccessThe grasper-integrated disposable flexible cystoscope is comparable to the reusable, flexible cystoscope for the detection of bladder cancer
- Raouf M. Seyam
- , Omar M. Zeitouni
- & Waleed M. Altaweel
-
Article
| Open AccessCirculating proteomic signature for detection of biomarkers in bladder cancer patients
- Taoufik Nedjadi
- , Hicham Benabdelkamal
- & Jaudah Al-Maghrabi
-
Article
| Open AccessEpigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
- K. E. van der Vos
- , D. J. Vis
- & M. S. van der Heijden
-
Article
| Open AccessCritical role of SOX2–IGF2 signaling in aggressiveness of bladder cancer
- Yu-Fan Chiu
- , Chia-Chang Wu
- & Yu-Ting Chou
-
Article
| Open AccessAberrant expression of the COX2/PGE2 axis is induced by activation of the RAF/MEK/ERK pathway in BRAFV595E canine urothelial carcinoma
- Ryohei Yoshitake
- , Kohei Saeki
- & Takayuki Nakagawa
-
Article
| Open AccessIncreased incidence of bladder cancer with metabolically unhealthy status: analysis from the National Health Checkup database in Korea
- Jong Wook Kim
- , Sun Tae Ahn
- & Hong Seok Park
-
Article
| Open AccessUrinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
- Stefanie Hiltbrunner
- , Michael Mints
- & Susanne Gabrielsson
-
Article
| Open AccessBasic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator
ODC1 - Lars Erichsen
- , Hans-Helge Seifert
- & Simeon Santourlidis
-
Article
| Open AccessExpression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
- Maihulan Maimaiti
- , Shinichi Sakamoto
- & Tomohiko Ichikawa
-
Article
| Open AccessFibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
- Artur Mezheyeuski
- , Ulrika Segersten
- & Carina Strell